Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma

BACKGROUND: We performed subgroup analyses of the AFTER I-O study to clarify the association of time-to-treatment failure (TTF) and discontinuation reason of prior immune-oncology (I-O) therapy, and molecular targeted therapy (TT) regimen with the outcomes of TT after I-O. METHODS: The data of Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yoshihiko, Kimura, Go, Fukasawa, Satoshi, Numakura, Kazuyuki, Sugiyama, Yutaka, Yamana, Kazutoshi, Naito, Sei, Kaneko, Hirokazu, Tajima, Yohei, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558912/
https://www.ncbi.nlm.nih.gov/pubmed/34350454
http://dx.doi.org/10.1093/jjco/hyab114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558912/
https://www.ncbi.nlm.nih.gov/pubmed/34350454
http://dx.doi.org/10.1093/jjco/hyab114

Ejemplares similares